CN102065761B - 成像技术 - Google Patents
成像技术 Download PDFInfo
- Publication number
- CN102065761B CN102065761B CN200980121454.1A CN200980121454A CN102065761B CN 102065761 B CN102065761 B CN 102065761B CN 200980121454 A CN200980121454 A CN 200980121454A CN 102065761 B CN102065761 B CN 102065761B
- Authority
- CN
- China
- Prior art keywords
- oxygen
- tissue
- blood
- mri
- experimenter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003384 imaging method Methods 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 claims abstract description 120
- 239000007789 gas Substances 0.000 claims abstract description 55
- 238000004422 calculation algorithm Methods 0.000 claims abstract description 41
- 230000036961 partial effect Effects 0.000 claims abstract description 17
- 230000007102 metabolic function Effects 0.000 claims abstract description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 204
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 203
- 239000001301 oxygen Substances 0.000 claims description 202
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 63
- 239000008280 blood Substances 0.000 claims description 62
- 206010028980 Neoplasm Diseases 0.000 claims description 61
- 210000004369 blood Anatomy 0.000 claims description 61
- 230000008520 organization Effects 0.000 claims description 32
- 238000005481 NMR spectroscopy Methods 0.000 claims description 25
- 230000002503 metabolic effect Effects 0.000 claims description 22
- 230000008557 oxygen metabolism Effects 0.000 claims description 21
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 21
- 230000000007 visual effect Effects 0.000 claims description 16
- 238000005259 measurement Methods 0.000 claims description 15
- 230000004060 metabolic process Effects 0.000 claims description 13
- 238000009792 diffusion process Methods 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 7
- 230000002792 vascular Effects 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 5
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000037323 metabolic rate Effects 0.000 claims description 2
- 230000005298 paramagnetic effect Effects 0.000 abstract description 3
- 238000012512 characterization method Methods 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 107
- 230000006870 function Effects 0.000 description 46
- 239000002872 contrast media Substances 0.000 description 37
- 229940039231 contrast media Drugs 0.000 description 33
- 230000008569 process Effects 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 201000010099 disease Diseases 0.000 description 18
- 238000012360 testing method Methods 0.000 description 13
- 230000008901 benefit Effects 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 210000002381 plasma Anatomy 0.000 description 11
- 238000004393 prognosis Methods 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 238000003745 diagnosis Methods 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 8
- 230000005408 paramagnetism Effects 0.000 description 8
- 239000000443 aerosol Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 238000012905 input function Methods 0.000 description 6
- 230000005291 magnetic effect Effects 0.000 description 6
- 238000002600 positron emission tomography Methods 0.000 description 6
- 238000004088 simulation Methods 0.000 description 6
- 210000000709 aorta Anatomy 0.000 description 5
- 229940000406 drug candidate Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000036284 oxygen consumption Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000003862 health status Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000010412 perfusion Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000035479 physiological effects, processes and functions Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000002059 diagnostic imaging Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 210000003701 histiocyte Anatomy 0.000 description 3
- 230000000222 hyperoxic effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000007310 pathophysiology Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 229910052688 Gadolinium Inorganic materials 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010058490 Hyperoxia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000004098 cellular respiration Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 230000000155 isotopic effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000009206 nuclear medicine Methods 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 208000005069 pulmonary fibrosis Diseases 0.000 description 2
- 230000009325 pulmonary function Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061968 Gastric neoplasm Diseases 0.000 description 1
- 206010018873 Haemoconcentration Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- 238000012897 Levenberg–Marquardt algorithm Methods 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OTCCIMWXFLJLIA-UHFFFAOYSA-N N-acetyl-DL-aspartic acid Natural products CC(=O)NC(C(O)=O)CC(O)=O OTCCIMWXFLJLIA-UHFFFAOYSA-N 0.000 description 1
- OTCCIMWXFLJLIA-BYPYZUCNSA-N N-acetyl-L-aspartic acid Chemical compound CC(=O)N[C@H](C(O)=O)CC(O)=O OTCCIMWXFLJLIA-BYPYZUCNSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 238000012879 PET imaging Methods 0.000 description 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000007488 abnormal function Effects 0.000 description 1
- 208000037844 advanced solid tumor Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013499 data model Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- HZHFFEYYPYZMNU-UHFFFAOYSA-K gadodiamide Chemical compound [Gd+3].CNC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)NC HZHFFEYYPYZMNU-UHFFFAOYSA-K 0.000 description 1
- 201000006585 gastric adenocarcinoma Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000012120 mounting media Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002626 targeted therapy Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000000287 tissue oxygenation Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
- A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- High Energy & Nuclear Physics (AREA)
- Immunology (AREA)
- Radiology & Medical Imaging (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Abstract
Description
Claims (18)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0807144.1 | 2008-04-18 | ||
GB0807144A GB0807144D0 (en) | 2008-04-18 | 2008-04-18 | Imaging technique |
GB0905803A GB0905803D0 (en) | 2009-04-03 | 2009-04-03 | Imaging technique |
GB0905803.3 | 2009-04-03 | ||
PCT/GB2009/000979 WO2009127827A1 (en) | 2008-04-18 | 2009-04-17 | Imaging technique |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102065761A CN102065761A (zh) | 2011-05-18 |
CN102065761B true CN102065761B (zh) | 2014-09-03 |
Family
ID=40786540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980121454.1A Expired - Fee Related CN102065761B (zh) | 2008-04-18 | 2009-04-17 | 成像技术 |
Country Status (6)
Country | Link |
---|---|
US (1) | US8774898B2 (zh) |
EP (1) | EP2271257B1 (zh) |
JP (1) | JP5612565B2 (zh) |
CN (1) | CN102065761B (zh) |
CA (1) | CA2758393A1 (zh) |
WO (1) | WO2009127827A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009127827A1 (en) * | 2008-04-18 | 2009-10-22 | The University Of Manchester | Imaging technique |
US20110028828A1 (en) * | 2009-08-01 | 2011-02-03 | Dania Daye | T1 rho magnetic resonance imaging for staging of hepatic fibrosis |
GB0919269D0 (en) | 2009-11-03 | 2009-12-16 | Univ Manchester | Lung function analysis method and apparatus |
JP5859835B2 (ja) * | 2011-12-08 | 2016-02-16 | 大陽日酸株式会社 | コンパートメント解析システム、コンパートメント解析方法、コンパートメント解析装置、プログラム、及び記録媒体 |
GB201221305D0 (en) * | 2012-11-27 | 2013-01-09 | Greater Glasgow Health Board | Improved methods of assessing metabolic function |
GB201304728D0 (en) * | 2013-03-15 | 2013-05-01 | Isis Innovation | Medical imaging |
US10335048B2 (en) * | 2013-11-15 | 2019-07-02 | Oregon Health & Science University | High-resolution metabolic neuroimaging |
FR3027115B1 (fr) * | 2014-10-13 | 2019-05-10 | Olea Medical | Systeme et procede pour estimer une quantite d'interet d'un systeme dynamique artere/tissu/veine |
WO2023286040A1 (en) * | 2021-07-16 | 2023-01-19 | Joseph Arnold Fisher | Implementing a periodic deoxyhemoglobin signal |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5706805A (en) * | 1993-08-12 | 1998-01-13 | Trustees Of Dartmouth College | Apparatus and methodology for determining oxygen tension in biological systems |
US5694934A (en) * | 1996-04-17 | 1997-12-09 | Beth Israel Hospital | MR studies in which a paramagnetic gas is administered to a living patient |
US6370415B1 (en) * | 1998-04-10 | 2002-04-09 | Medi-Physics Inc. | Magnetic resonance imaging method |
US20020010550A1 (en) * | 1998-09-14 | 2002-01-24 | George M. Grass | Pharmacokinetic-based drug design tool and method |
EP1139109A1 (en) * | 2000-03-28 | 2001-10-04 | Bracco International B.V. | A method for magnetic resonance imaging of the lung |
US6915151B2 (en) * | 2001-02-08 | 2005-07-05 | Trustees Of The University Of Pennsylvania | Quantitative pulmonary imaging |
US7072706B2 (en) * | 2001-02-08 | 2006-07-04 | The Trustees Of The University Of Pennsylvania | Equilibration method for high resolution imaging of lung compliance and distribution of functional residual capacity |
US7179450B2 (en) * | 2001-09-20 | 2007-02-20 | Medi-Physics, Inc. | Methods for in vivo evaluation of pulmonary physiology and/or function using NMR signals of polarized Xe |
US7278420B2 (en) * | 2002-09-24 | 2007-10-09 | Thomas Jefferson University | Oropharyngeal airway |
ES2347790T3 (es) * | 2003-04-22 | 2010-11-04 | Medi-Physics, Inc. | Valvula para conduccion de gas hiperpolarizado. |
EP1912694A4 (en) * | 2005-07-28 | 2011-11-09 | Marat Slessarev | METHOD AND DEVICE FOR ACHIEVING AND MAINTAINING DESIRED END TIDAL GAS CONCENTRATIONS |
GB0616810D0 (en) * | 2006-08-25 | 2006-10-04 | Greater Glasgow Nhs Board | Method of imaging metabolic function |
GB0708567D0 (en) * | 2007-05-03 | 2007-06-13 | Univ Manchester | Imaging technique |
WO2009014998A1 (en) * | 2007-07-20 | 2009-01-29 | The Trustees Of The University Of Pennsylvania | Method and apparatus for providing pulsed inhalation of 17o2 for magnetic resonance imaging of cerebral metabolism |
WO2009127827A1 (en) * | 2008-04-18 | 2009-10-22 | The University Of Manchester | Imaging technique |
GB0919269D0 (en) * | 2009-11-03 | 2009-12-16 | Univ Manchester | Lung function analysis method and apparatus |
-
2009
- 2009-04-17 WO PCT/GB2009/000979 patent/WO2009127827A1/en active Application Filing
- 2009-04-17 JP JP2011504528A patent/JP5612565B2/ja not_active Expired - Fee Related
- 2009-04-17 EP EP09733625.9A patent/EP2271257B1/en not_active Not-in-force
- 2009-04-17 US US12/988,018 patent/US8774898B2/en not_active Expired - Fee Related
- 2009-04-17 CA CA2758393A patent/CA2758393A1/en not_active Abandoned
- 2009-04-17 CN CN200980121454.1A patent/CN102065761B/zh not_active Expired - Fee Related
Non-Patent Citations (5)
Title |
---|
Alfred Stadler等.Quantitative and O2 Enhanced MRI of the Pathologic Lung:Findings in Emphysema, Fibrosis, and Cystic Fibrosis.《International Journal of Biomedical Imaging》.2007,第2007卷 * |
Dynamic Oxygen-Enhanced MRI Reflects Diffusing Capacity of the Lung;Yoshiharu Ohno等;《Magnetic Resonance in Medicine》;20021231;第47卷;第1140-143页 * |
Improved Quantitative Dynamic Regional Oxygen-Enhanced Pulmonary Imaging Using Image Registration;Josephine H. Naish等;《Magnetic Resonance in Medicine》;20051231;第54卷;第464-465页 * |
Josephine H. Naish等.Improved Quantitative Dynamic Regional Oxygen-Enhanced Pulmonary Imaging Using Image Registration.《Magnetic Resonance in Medicine》.2005,第54卷第464-469页. |
Yoshiharu Ohno等.Dynamic Oxygen-Enhanced MRI Reflects Diffusing Capacity of the Lung.《Magnetic Resonance in Medicine》.2002,第47卷第1139-1144页. |
Also Published As
Publication number | Publication date |
---|---|
JP2011519291A (ja) | 2011-07-07 |
JP5612565B2 (ja) | 2014-10-22 |
WO2009127827A1 (en) | 2009-10-22 |
CN102065761A (zh) | 2011-05-18 |
EP2271257A1 (en) | 2011-01-12 |
US20110035198A1 (en) | 2011-02-10 |
CA2758393A1 (en) | 2009-10-22 |
US8774898B2 (en) | 2014-07-08 |
EP2271257B1 (en) | 2014-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102065761B (zh) | 成像技术 | |
Ohno et al. | Oxygen-enhanced MR ventilation imaging of the lung: preliminary clinical experience in 25 subjects | |
CN102083366B (zh) | 用于对组织内变化进行成像的系统和方法 | |
Kauczor et al. | Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application | |
CN101506842B (zh) | 灌注成像的方法 | |
Ohno et al. | Pulmonary functional imaging: Part 1—state-of-the-art technical and physiologic underpinnings | |
Biffar et al. | Quantitative analysis of vertebral bone marrow perfusion using dynamic contrast‐enhanced MRI: Initial results in osteoporotic patients with acute vertebral fracture | |
CN101720203B (zh) | 成像技术 | |
CN1895185B (zh) | 显示检查对象的检查区域和药剂在体内影响的信息的方法 | |
CN113329688B (zh) | 用于确定组织体素的特征的方法、系统和计算机可读介质 | |
Fliss et al. | Hyperpolarized 129Xe magnetic resonance spectroscopy in a rat model of bronchopulmonary dysplasia | |
Beyer et al. | Medical Physics and Imaging–A Timely Perspective | |
Stadler et al. | Quantitative and O2 enhanced MRI of the pathologic lung: findings in emphysema, fibrosis, and cystic fibrosis | |
Herrmann et al. | Assessment of heterogeneity in lung structure and function during mechanical ventilation: a review of methodologies | |
Ley-Zaporozhan et al. | Proton MRI in COPD | |
WO2012011872A1 (en) | A method and/or system for determining portal hemodynamics of a subject | |
Agarwal et al. | Detection and mitigation of neurovascular uncoupling in brain gliomas | |
Triphan et al. | Magnetic resonance imaging of lung perfusion | |
Jørgensen et al. | Reproducibility of contrast enhanced magnetic resonance renography in adolescents | |
Lu | 3D Mouse Lung Cancer Phantom Development and MRI Performance Evaluation | |
JP3346673B2 (ja) | 生体計測システム | |
Aguado Sarrió | Application of multivariate image analysis to prostate cancer for improving the comprehension of the related physiological phenomena and the development and validation of new imaging biomarkers | |
Bluemke | Magnetic resonance imaging of oxygen nano-carriers for the treatment of hypoxic tumours | |
Pippard | Assessing pulmonary ventilation and perfusion properties with 19F-MRI | |
Sarrió et al. | Application of multivariate image analysis to prostate cancer for improving the comprehension of the related physiological phenomena and the development and validation of new imaging biomarkers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BIOXYDYN LTD. Free format text: FORMER OWNER: UNIVERSITY OF MANCHESTER Effective date: 20131226 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20131226 Address after: University of Manchester Applicant after: The University of Manchester Address before: University of Manchester Applicant before: University of Manchester |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140903 Termination date: 20200417 |
|
CF01 | Termination of patent right due to non-payment of annual fee |